(function(){var loadHandler=window['sl_{21FEF8D7-4385-4DEB-B34B-7A4BB675EF9A}'];loadHandler&&loadHandler(10, '<div id="spr0_15873487"><div id="spr1_15873487" class="kern slide"><img id="img4_15873487" src="data/img8.png" width="720px" height="540px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_15873487" class="kern slide"><img id="img0_15873487" src="data/img17.png" width="721.48" height="46.226" alt="" style="left:-0.439px;top:493.774px;"/><img id="img1_15873487" src="data/img1.png" width="721.48" height="100.8" alt="" style="left:-0.439px;"/><div id="spr3_15873487" style="left:657.715px;top:502.143px;"><img id="img2_15873487" src="data/img3.png" width="56" height="36" alt="CHRC logo_with text.psd" style="left:-0.105px;top:-0.177px;"/></div><div id="spr4_15873487" style="left:28.702px;top:-3.551px;"><div style="width:0px;"><span id="txt0_15873487" class="relpos" style="left:188.702px;top:5.458px;"> </span><span id="txt1_15873487" class="relpos" data-width="295.294922" style="left:188.697px;top:9.189px;">ODYSSEY Outcomes</span></div><div style="width:0px;"><span id="txt2_15873487" data-width="551.109375" style="left:66.727px;top:53.272px;">LDL-C: ITT and On-Treatment Analyses</span></div></div><div id="spr5_15873487" style="left:19.805px;top:508.807px;"><div style="width:0px;"><span id="txt3_15873487" class="nokern relpos" data-width="45.140625" style="left:9.321px;top:6.217px;">Steg G. et al; </span><span id="txt4_15873487" class="nokern relpos" data-width="489.001465" style="left:9.316px;top:6.217px;">On behalf of the ODYSSEY OUTCOMES Investigators and Committees - American College of Cardiology – 67th Scientific Sessions - March 10, 2018</span></div></div><div id="spr6_15873487" style="left:19.805px;top:508.807px;"><div style="width:0px;"><span id="txt5_15873487" class="nokern relpos" data-width="45.140625" style="left:7.2px;top:4.096px;">Steg G. et al; </span><span id="txt6_15873487" class="nokern relpos" data-width="489.001465" style="left:7.195px;top:4.096px;">On behalf of the ODYSSEY OUTCOMES Investigators and Committees - American College of Cardiology – 67th Scientific Sessions - March 10, 2018</span></div></div><div id="spr7_15873487" style="left:0.507px;top:434.573px;"><div style="width:0px;"><span id="txt7_15873487" data-width="481.831055" style="left:7.2px;top:4.371px;">*Excludes LDL-C values after premature treatment discontinuation or blinded switch to placebo</span></div><div style="width:0px;"><span id="txt8_15873487" class="relpos" style="left:7.2px;top:21.171px;">†</span><span id="txt9_15873487" class="relpos" data-width="644.594727" style="left:7.195px;top:21.171px;">All LDL-C values, including those after premature treatment discontinuation, blinded down titration, or blinded switch to placebo</span></div></div><div id="spr8_15873487" style="left:1.969px;top:114.277px;"><img id="img3_15873487" src="data/img26.png" width="735" height="375" alt="" style="left:-0.007px;top:0.156px;"/></div></div></div>');})();